{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-347196","form_type":"8-K","ticker":"SLN","cik":"0001479615","company_name":"Silence Therapeutics plc","filed_at":"2026-08-12T21:23:33+00:00","discovered_at":"2026-08-12T21:26:04.226395+00:00","generated_at":"2026-08-12T21:26:22.967484+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Silence Therapeutics prices $175M ADS offering at $13.50 per share","bullets":["Priced 12,962,963 ADSs at $13.50 each; gross proceeds ~$175M before expenses.","Underwriters' 30-day option for up to 1,944,444 additional ADSs; net proceeds ~$164.0M (~$188.7M if option exercised).","Closing expected Aug 13, 2026; Jefferies, Morgan Stanley, Cantor and William Blair act as joint book-runners.","Underwriters purchase price $12.69 per ADS; offering under shelf registration on Form S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-347196","json":"https://secwatch.observer/filing/0001193125-26-347196.json","markdown":"https://secwatch.observer/filing/0001193125-26-347196.md","text":"https://secwatch.observer/filing/0001193125-26-347196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/0001193125-26-347196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/d168365d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T21:26:22.967484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}